MODY2 diagnostic issues in adults
Irina V. Kononenko,
Anastasiya A. Glibka,
Natalya A. Zubkova,
Alexander Y. Mayorov,
Anatoly N. Tyulpakov,
Olga M. Schmidt https://doi.org/10.14341/DM10063
Abstract
Approximately 90% of all cases of diabetes mellitus in adults involve type 2 diabetes, while the prevalence of maturity-onset diabetes of the young (MODY) remains undetermined leading to inappropriate treatment regimens. One of the most common monogenic forms of diabetes is a disease caused by a mutation in the glucokinase gene, MODY2. Knowledge of the clinical features of the disease allows the selection of patients with a high risk of mutation in the glucokinase gene and verification of diagnosis for molecular genetic research. This paper reflects the clinical features of MODY2 and the difficulties of diagnosis in adults. Furthermore, it presents a clinical case of a patient with MODY2 demonstrating all the features of this type of diabetes. A family member with a mutation in the gene allows to predict the nature of carbohydrate metabolism disorders in first degree relatives. A targeted study of only one part of the glucokinase gene in molecular genetic research is sufficient to confirm the diagnosis in relatives.
About the Authors
Irina V. Kononenko
Endocrinology Research Centre
Russian Federation
Russian Federation
PhD
Anastasiya A. Glibka
Endocrinology Research Centre
Russian Federation
Russian Federation
MD, PhD student
Natalya A. Zubkova
Endocrinology Research Centre
Russian Federation
Russian Federation
PhD
Alexander Y. Mayorov
Endocrinology Research Centre
Russian Federation
Russian Federation
MD, PhD
Anatoly N. Tyulpakov
Endocrinology Research Centre
MD, PhD
Olga M. Schmidt
Endocrinology Research Centre
Russian Federation
Russian Federation
MD
References
1. Shields BM, Peters JL, Cooper C, et al. Can clinical features be used to differentiate type 1 from type 2 diabetes? A systematic review of the literature. BMJ Open. 2015;5(11):e009088. doi: https://doi.org/10.1136/bmjopen-2015-009088
2. Кураева Т.Л., Сечко Е.А., Зильберман Л.И., и др. Молекулярно-генетические и клинические варианты MODY2 и MODY3 у детей в России // Проблемы эндокринологии. — 2015. — Т. 61. — №5. — С. 14-25. [Kuraeva TL, Sechko EA, Zilberman LI, et al. Molecular genetic and clinical variants MODY2 and MODY3 in children in Russia. Problems of Endocrinology. 2016;61(5):14-25. (In Russ.)] doi: https://doi.org/10.14341/probl201561514-25
3. Pihoker C, Gilliam LK, Ellard S, et al. Prevalence, Characteristics and Clinical Diagnosis of Maturity Onset Diabetes of the Young Due to Mutations in HNF1A, HNF4A, and Glucokinase: Results From the SEARCH for Diabetes in Youth. J Clin Endocrinol Metab. 2013;98(10):4055-4062. doi: https://doi.org/10.1210/jc.2013-1279
4. Bishay RH, Greenfield JR. A review of maturity onset diabetes of the young (MODY) and challenges in the management of glucokinase-MODY. Med J Aust. 2016;205(10):480-485. doi: https://doi.org/10.5694/mja16.00458
5. Amed S, Dean HJ, Panagiotopoulos C, et al. Type 2 Diabetes, Medication-Induced Diabetes, and Monogenic Diabetes in Canadian Children: A prospective national surveillance study. Diabetes Care. 2010;33(4):786-791. doi: https://doi.org/10.2337/dc09-1013
6. DellaManna T, Silva MRd, Chacra AR, et al. Clinical follow-up of two Brazilian subjects with glucokinase-MODY (MODY2) with description of a novel mutation. Arq Bras Endocrinol Metabol. 2012;56(8):490-495. doi: https://doi.org/10.1590/s0004-27302012000800005
7. Pruhova S, Dusatkova P, Sumnik Z, et al. Glucokinase diabetes in 103 families from a country-based study in the Czech Republic: geographically restricted distribution of two prevalent GCK mutations. Pediatr Diabetes. 2010;11(8):529-535. doi: https://doi.org/10.1111/j.1399-5448.2010.00646.x
8. Stern E, Strihan C, Potievsky O, et al. Four novel mutations, including the first gross deletion in TCF1, identified in HNF-4alpha, GCK and TCF1 in patients with MODY in Israel. J Pediatr Endocrinol Metab. 2007;20(8):909-921. doi: https://doi.org/10.1515/jpem.2007.20.8.909
9. Shields BM, Hicks S, Shepherd MH, et al. Maturity-onset diabetes of the young (MODY): how many cases are we missing? Diabetologia. 2010;53(12):2504-2508. doi: https://doi.org/10.1007/s00125-010-1799-4
10. Firdous P, Nissar K, Ali S, et al. Genetic Testing of Maturity-Onset Diabetes of the Young Current Status and Future Perspectives. Front Endocrinol (Lausanne). 2018;9. doi: https://doi.org/10.3389/fendo.2018.00253
11. Chakera AJ, Steele AM, Gloyn AL, et al. Recognition and Management of Individuals With Hyperglycemia Because of a Heterozygous Glucokinase Mutation. Diabetes Care. 2015;38(7):1383-1392. doi: https://doi.org/10.2337/dc14-2769
12. Njolstad PR, Sagen JV, Bjorkhaug L, et al. Permanent Neonatal Diabetes Caused by Glucokinase Deficiency: Inborn Error of the Glucose-Insulin Signaling Pathway. Diabetes. 2003;52(11):2854-2860. doi: https://doi.org/10.2337/diabetes.52.11.2854
13. Singh R, Pearson ER, Clark PM, Hattersley AT. The long-term impact on offspring of exposure to hyperglycaemia in utero due to maternal glucokinase gene mutations. Diabetologia. 2007;50(3):620-624. doi: https://doi.org/10.1007/s00125-006-0541-8
14. Зубкова Н.А., Бурумкулова Ф.Ф., Улятовская В.И., и др. Весо-ростовые показатели детей, рожденных от матерей с гестационным сахарным диабетом, обусловленным мутациями в гене глюкокиназы // Сахарный диабет. — 2018 — Т. 21. — №2. — С. 92-98. [Zubkova NA, Burumkulova FF, Ulyatovskaya VI, et al. Birth weight and length in offsprings of mothers with gestational diabetes mellitus due to mutations in GCK gene. Diabetes mellitus. 2018;21(2):92-98. (In Russ.)] doi: https://doi.org/10.14341/DM9429
15. Меликян М.А., Карева М.А. Врожденный гиперинсулинизм: Пособие для врачей. — М.; 2017. [Melikyan MА, Kareva MА. Vrozhdennyy giperinsulinizm: Manual for doctors. Moscow; 2017. (In Russ.)]
16. Anık A, Çatlı G, Abacı A, Böber E. Maturity-onset diabetes of the young (MODY): an update. J Pediatr Endocrinol Metab. 2015;28(3-4). doi: https://doi.org/10.1515/jpem-2014-0384
17. Ellard S, Beards F, Allen LIS, et al. A high prevalence of glucokinase mutations in gestational diabetic subjects selected by clinical criteria. Diabetologia. 2000;43(2):250-253. doi: https://doi.org/10.1007/s001250050038
18. Lachance C-H. Practical Aspects of Monogenic Diabetes: A Clinical Point of View. Can J Diabetes. 2016;40(5):368-375. doi: https://doi.org/10.1016/j.jcjd.2015.11.004
19. Кураева Т.Л., Зильберман Л.И., Титович Е.В., и др. Генетика моногенных форм сахарного диабета // Сахарный диабет. — 2011 — Т. 14. — №1. — С. 20-27. [Kuraeva TL, Zil’berman LI, Titovich EV, et al. Genetics of monegenic forms of diabetes mellitus. Diabetes mellitus. 2011;14(1):20-27. (In Russ.)] doi: https://doi.org/10.14341/2072-0351-6246.
20. Froguel P, Vaxillaire M, Sun F, et al. Close linkage of glucokinase locus on chromosome 7p to early-onset non-insulin-dependent diabetes mellitus. Nature. 1992;356(6365):162-164. doi: https://doi.org/10.1038/356162a0
21. Солвей Дж.Г. Наглядная медицинская биохимия: учебное пособие. / Под ред. Северина Е.С. — М.: ГЭОТАР-Медиа; 2015. [Solvay JG. Severin ES, editor. Naglyadnaya meditsinskaya biokhimiya: tutorial. Moscow: GEOTАR-Media; 2015. (In Russ.)]
22. Lu B, Munoz-Gomez M, Ikeda Y. The two major glucokinase isoforms show conserved functionality in β-cells despite different subcellular distribution. Biol Chem. 2018;399(6):565-576. doi: https://doi.org/10.1515/hsz-2018-0109
23. hgmd.cf.ac.uk [Internet]. The Human Gene Mutation Database [cited 2019 Jan 23]. Available from: http://www.hgmd.cf.ac.uk/ac/index.php.
24. Osbak KK, Colclough K, Saint-Martin C, et al. Update on mutations in glucokinase (GCK), which cause maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemic hypoglycemia. Hum Mutat. 2009;30(11):1512-1526. doi: https://doi.org/10.1002/humu.21110
25. Froguel P, Zouali H, Vionnet N, et al. Familial Hyperglycemia Due to Mutations in Glucokinase -- Definition of a Subtype of Diabetes Mellitus. New Eng J Med. 1993;328(10):697-702. doi: https://doi.org/10.1056/nejm199303113281005
26. Velho G, Hattersley AT, Froguel P. Maternal diabetes alters birth weight in glucokinase-deficient (MODY2) kindred but has no influence on adult weight, height, insulin secretion or insulin sensitivity. Diabetologia. 2000;43(8):1060-1063. doi: https://doi.org/10.1007/s001250051490
27. Colom C, Corcoy R. Maturity onset diabetes of the young and pregnancy. Best Pract Res Clin Endocrinol Metab. 2010;24(4):605-615. doi: https://doi.org/10.1016/j.beem.2010.05.008
28. Dickens LT, Naylor RN. Clinical Management of Women with Monogenic Diabetes During Pregnancy. Curr Diab Rep. 2018;18(3). doi: https://doi.org/10.1007/s11892-018-0982-8
29. Njølstad PR, Molven A. To test, or not to test: time for a MODY calculator? Diabetologia. 2012;55(5):1231-1234. doi: https://doi.org/10.1007/s00125-012-2514-4
30. diabetesgenes.org [Internet]. MODY Probability Calculator [cited 2019 Jan 23]. Available from: https://www.diabetesgenes.org/mody-probability-calculator .
Supplementary files
|
|
1. Fig. 1. Family tree of the patient I. Notes: NUO - disorders of carbohydrate metabolism. MGI - molecular genetic research | |
| Subject | ||
| Type | Other | |
View
(498KB)
|
Indexing metadata ▾ | |
|
|
2. Fig. 2. The MODY calculator [5, 23]. Adapted from [30]. | |
| Subject | ||
| Type | Other | |
View
(351KB)
|
Indexing metadata ▾ | |
Review
For citations:
Kononenko I.V., Glibka A.A., Zubkova N.A., Mayorov A.Y., Tyulpakov A.N., Schmidt O.M. MODY2 diagnostic issues in adults. Diabetes mellitus. 2019;22(4):384-391. (In Russ.) https://doi.org/10.14341/DM10063
Views:
3921
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
